Market Tracker

06/23 5:16pm ET

United Therapeutics Corp (NASDAQ:UTHR)

131.59
Delayed Data
As of Jun 23
 -0.11 / -0.08%
Today’s Change
97.52
Today|||52-Week Range
169.89
-8.25%
Year-to-Date
Argan and Sturm Ruger Show High Profit and Low Debt
Jun 20 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close131.70
Today’s open131.86
Day’s range130.76 - 132.87
Volume1,195,642
Average volume (3 months)612,299
Market cap$5.9B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-7.59%
Earnings growth (next 5 years)-6.70%
Revenue growth (last year)+9.08%
P/E ratio9.2
Price/Sales4.20
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.25-1.11%
VRXValeant Pharmaceutic...+0.30+1.94%
PTHNPatheon NV+0.05+0.14%
IONSIonis Pharmaceutical...+0.25+0.46%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$3.49
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts